Guidant v. Medtronic
This article was originally published in The Gray Sheet
Executive Summary
Delaware federal court jury affirms that Medtronic Driver and S7 coronary stents infringe Guidant's Lau patents, and that the patents are valid. The move is in-line with a Jan. 5 ruling and overturns a subsequent reversal (1"The Gray Sheet" Jan. 10, 2005, p. 3). Medtronic says its next step will be to pursue an unenforceability claim for "inequitable conduct," and that the current findings do not affect U.S. sales of the devices...
You may also be interested in...
Medtronic Stent Patent Ruling Makes DES Vulnerable; Will Guidant Cut Deal?
Medtronic will appeal a Delaware federal court patent infringement ruling against its Driver and S7 coronary stents and challenge the validity of Guidant's Lau patent, the firm says
‘Clear’ Is In The Eye Of The Beholder, New York, CRN Argue In Age-Restricted Sales Litigation
CRN’s request for clarification, as it continues litigating complaint in US District Court for Southern New York, highlights what it contends is vague and overly general language in the legislation passed in October with a 22 April effective date.
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.